Cohen Robert 4
4 · Zomedica Corp. · Filed Jun 30, 2021
Insider Transaction Report
Form 4
Cohen Robert
Director
Transactions
- Exercise/Conversion
Stock option (right to buy)
2021-06-30−543,750→ 10,262,500 totalExercise: $0.23Exp: 2030-12-30→ Common Stock, without par value (543,750 underlying) - Exercise/Conversion
Common Stock, without par value
2021-06-30$0.23/sh+543,750$125,063→ 543,750 total - Sale
Common Stock, without par value
2021-06-30$0.82/sh−543,750$447,343→ 0 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.815 to $0.845 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F3]The option vests as to 50% of the shares on December 31, 2020 with the remainder in 2 equal annual installments commencing December 31, 2021.